MedPath

A Trial of Rigid Versus Semirigid Thoracoscopy in the Evaluation of Exudative Pleural Effusions

Not Applicable
Completed
Conditions
Pleurisy With Effusion
Interventions
Device: Rigid thoracoscope (Richard Wolf GmbH, Knittlingen, Germany)
Device: Semirigid thoracoscope (model LTF-160Y1, Olympus, Japan)
Registration Number
NCT01726556
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Brief Summary

Rigid thoracoscopy is an established procedure for the performance of pleural biopsies for undiagnosed pleural effusions. The semirigid thoracoscope is a relatively new instrument designed for the same purpose which is claimed to be more user-friendly. The two devices have not been compared in a head-to-head trial in published literature. The investigators attempt to conduct a randomised comparative trial between the two devices.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients with an exudative (as defined by Light's criteria) pleural effusion of unknown etiology after a microbiological (namely gram stain and acid fast bacillus stain) and cytological examination
Exclusion Criteria
  • Significant hypoxemia on room air
  • Hemodynamic instability
  • Significant cardiac disease (known myocardial infarction in last 6 weeks or presence of unstable angina)
  • Refractory cough
  • Lack of pleural space due to adhesions
  • Uncorrected coagulopathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Rigid thoracoscopyRigid thoracoscope (Richard Wolf GmbH, Knittlingen, Germany)Rigid thoracoscopy would be done using a rigid thoracoscope manufactured by Richard Wolf GmbH, Knittlingen, Germany.
Semirigid thoracoscopySemirigid thoracoscope (model LTF-160Y1, Olympus, Japan)The semirigid thoracoscope employed is a model LTF-160Y1, manufactured by Olympus Medical Systems Corporation, Tokyo, Japan.
Primary Outcome Measures
NameTimeMethod
Diagnostic yield of thoracoscopic biopsy by intention to treat analysis3 months

The proportion of patients where thoracoscopic pleural biopsy yielded a diagnosis that was consistent with the present clinical picture and the further follow-up of the patients, would be calculated and compared between the two arms

Secondary Outcome Measures
NameTimeMethod
Yield of biopsies successfully completed3 months

The diagnostic yield of only those procedures would be considered separately where a biopsy could be successfully done and compared between the two arms

Complications3 months

Number of major and minor complications encountered in the two arms

Scar sizeAt the end of the procedure

Scar size (in mm) in the longest axis

Biopsy sizeAt the end of the procedure

Biopsy size (in mm) in the longest axis

Trial Locations

Locations (1)

Postgraduate Institute of Medical Education and Research

🇮🇳

Chandigarh, India

© Copyright 2025. All Rights Reserved by MedPath